ストックスクリーナーアプリを入手
3.91
4.17%
-0.17
アフターアワーズ：
3.95
0.04
+1.02%
前日終値:
$4.08
開ける：
$4.11
24時間の取引高:
2.33M
Relative Volume:
2.26
時価総額：
$326.56M
収益：
$195.82M
当期純損益:
$-88.78M
株価収益率:
-1.5585
EPS:
-2.5089
ネットキャッシュフロー:
$-88.86M
1週間 パフォーマンス:
-36.42%
1か月 パフォーマンス:
-28.91%
6か月 パフォーマンス:
-8.86%
1年 パフォーマンス:
-23.18%
1日の値動き範囲:
$3.865
$4.11
1週間の範囲:
$3.865
$6.21
52週間の値動き範囲:
$3.4216
$7.20
Aurora Cannabis Inc. Stock (ACB) Company Profile
ACB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.91 | 326.56M | 195.82M | -88.78M | -88.86M | -2.5089 |
|
RGC
Regencell Bioscience Holdings Ltd
|
23.70 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
157.34 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.49 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.97 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-11 | 開始されました | TD Cowen | Buy |
| 2024-02-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2022-09-21 | アップグレード | Canaccord Genuity | Sell → Hold |
| 2022-06-24 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-06-06 | アップグレード | Stifel | Sell → Hold |
| 2021-09-28 | アップグレード | MKM Partners | Sell → Neutral |
| 2021-09-03 | アップグレード | Jefferies | Underperform → Hold |
| 2021-05-14 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
| 2021-05-14 | ダウングレード | Canaccord Genuity | Hold → Sell |
| 2021-05-11 | ダウングレード | CIBC | Neutral → Sector Underperform |
| 2021-04-28 | 再開されました | BofA Securities | Neutral |
| 2021-02-12 | ダウングレード | Desjardins | Hold → Sell |
| 2021-02-12 | ダウングレード | MKM Partners | Neutral → Sell |
| 2021-02-12 | ダウングレード | Needham | Hold → Underperform |
| 2020-12-18 | ダウングレード | BMO Capital Markets | Market Perform → Underperform |
| 2020-11-16 | ダウングレード | Jefferies | Hold → Underperform |
| 2020-11-11 | ダウングレード | Stifel | Hold → Sell |
| 2020-10-27 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-21 | アップグレード | Jefferies | Underperform → Hold |
| 2020-09-08 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-24 | アップグレード | Stifel | Sell → Hold |
| 2020-05-22 | ダウングレード | Jefferies | Hold → Underperform |
| 2020-05-15 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2020-02-27 | ダウングレード | Bryan Garnier | Neutral → Sell |
| 2020-02-25 | 開始されました | Needham | Hold |
| 2020-02-24 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-02-14 | アップグレード | MKM Partners | Sell → Neutral |
| 2020-02-07 | ダウングレード | Canaccord Genuity | Speculative Buy → Hold |
| 2020-01-10 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2020-01-10 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-12-23 | ダウングレード | Jefferies | Buy → Hold |
| 2019-11-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-11-05 | 開始されました | Cantor Fitzgerald | Neutral |
| 2019-09-24 | 開始されました | CIBC | Neutral |
すべてを表示
Aurora Cannabis Inc. (ACB) 最新ニュース
Aurora Cannabis Inc (ACB) (Q4 2025) Earnings Call Highlights: Re - GuruFocus
Aurora Cannabis Reports Record Revenue and Growth - TipRanks
Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics - StratCann
Aurora Cannabis Refutes MedLeaf Acquisition Rumors - mg Magazine
Aurora Cannabis announces new strategic partnership - Investing.com
Aurora Cannabis (ACB) Denies Acquisition of MedLeaf Therapeutics - GuruFocus
Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics - TipRanks
Aurora Cannabis denies acquisition of MedLeaf Therapeutics - Investing.com
Aurora Cannabis (ACB) Refutes Acquisition Rumors of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Denies News of Acquisition of MedLeaf Therapeutics - StreetInsider
Aurora Cannabis Denies News Of Acquisition Of MedLeaf Therapeutics - Barchart.com
Cannabis Stock Movers For June 18, 2025 - Benzinga
EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story - Benzinga
Aurora Cannabis Q4 2025 Earnings Call Transcript - MarketBeat
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade) (ACB) - Seeking Alpha
Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble - BNN Bloomberg
Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics - MJBizDaily
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics By Investing.com - Investing.com India
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics - Investing.com
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Benzinga
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline - MSN
Aurora Cannabis (ACB) Reports Significant Q4 Revenue Growth - GuruFocus
Aurora Cannabis Inc. - Baystreet.ca
Aurora Cannabis (ACB) Shares Tumble After Earnings Report | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Shares Drop Despite Exceeding Revenue Expe - GuruFocus
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates - Yahoo Finance
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 - TipRanks
Aurora Cannabis (ACB) Eyes First Profitable Year Amid Sector Cha - GuruFocus
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter - Placera.se
Aurora Cannabis Q4 Loss Narrows, Adj.EBITDA Surges; Sees Sequentially Weak Demand In Q1; Stock Drops - Nasdaq
ACB Projects Slight Dip in Q1 Revenue with Positive Cash Flow Ou - GuruFocus
Aurora Cannabis Q4 FY25 slides: positive cash flow achieved amid global expansion - Investing.com
Aurora Cannabis Files Full Year Results and Announces Fiscal 202 - GuruFocus
Aurora Cannabis (ACB) Reports Strong Q4 Adjusted EBITDA Growth | ACB Stock News - GuruFocus
ACB in charts: Q4 revenue from medical cannabis, plant propagation climb, consumer segment down - Seeking Alpha
Aurora Cannabis Files Full Year Results And Announces Fiscal 2025 Fourth Quarter - Barchart.com
Germany Legal Cannabis Market Report 2025-2030: Competitive - GlobeNewswire
Aurora Cannabis (ACB) Prepares for Earnings Announcement - GuruFocus
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday By Investing.com - Investing.com Nigeria
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday - Investing.com
Cannabis Hyperemesis Syndrome Class Action Certified - mg Magazine
Aurora Cannabis Faces Class Action Over Lack of Warnings About Cannabinoid Hyperemesis Syndrome - Cannabis Health News
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q4 2025 Earnings - Yahoo Finance
Aurora Cannabis: Poised For Its First Profitable Year (NASDAQ:ACB) - Seeking Alpha
Earnings week ahead: KR, ACN, ACB, and more (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis (ACB) Projected to Post Earnings on Wednesday - MarketBeat
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell? - The Globe and Mail
Aurora Cannabis Inc. (ACB) 財務データ
収益
当期純利益
現金流量
EPS
0.82%
0.53%
大文字化:
|
ボリューム (24 時間):